Telix Pharmaceuticals (Telix Pharmaceuticals) Other Current Payables : $32.7 Mil (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Telix Pharmaceuticals Other Current Payables?

Telix Pharmaceuticals's Other Current Payables for the quarter that ended in Dec. 2023 was $32.7 Mil.

Telix Pharmaceuticals's quarterly Other Current Payables declined from Dec. 2022 ($22.1 Mil) to Jun. 2023 ($0.0 Mil) but then increased from Jun. 2023 ($0.0 Mil) to Dec. 2023 ($32.7 Mil).

Telix Pharmaceuticals's annual Other Current Payables increased from Dec. 2021 ($5.1 Mil) to Dec. 2022 ($22.1 Mil) and increased from Dec. 2022 ($22.1 Mil) to Dec. 2023 ($32.7 Mil).

Telix Pharmaceuticals Other Current Payables Historical Data

The historical data trend for Telix Pharmaceuticals's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Telix Pharmaceuticals Other Current Payables Chart

Telix Pharmaceuticals Annual Data

Trend

Sep99

Sep00

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Payables

Get a 7-Day Free Trial

1.55

3.83

5.12

22.07

32.71

Telix Pharmaceuticals Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Current Payables	Get a 7-Day Free Trial								5.12	-	22.07	-	32.71

Telix Pharmaceuticals Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Telix Pharmaceuticals Other Current Payables Related Terms

Thank you for viewing the detailed overview of Telix Pharmaceuticals's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.

Telix Pharmaceuticals (Telix Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Telix Pharmaceuticals Ltd (OTCPK:TLPPF) » Definitions » Other Current Payables

Comparable Companies

Traded in Other Exchanges

TLX:Australia

Address

55 Flemington Road, Suite 401, North Melbourne, Melbourne, VIC, AUS, 3051

Website

https://www.telixpharma.com

Telix Pharmaceuticals Ltd is a clinical-stage biotechnology company engaged in developing and commercializing molecularly-targeted radiation therapy to address the unmet needs in the management of prostate, renal (kidney) and glioblastoma (brain) cancer. Geographically, it operates in Australia, the United States, Belgium, and Japan.